Page 6 - Calyxt Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Calyxt (CLXT) Announces Stockholder Approval of Merger With Cibus

Calyxt (CLXT) Announces Stockholder Approval of Merger With Cibus
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Cibus incCalyxt incCibus globalBroadridge corporate issuer solutions incStock splitNasdaq capital marketBroadridge corporate issuer solutions

Calyxt Announces Stockholder Approval of Merger With Cibus

/PRNewswire/ Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announced the results of the special meeting of its stockholders held on May 18,.

United statesColin sanfordSecurities exchangePrnewswire calyxt incCibus incCalyxt incCibus globalBroadridge corporate issuer solutions incStock splitNasdaq capital marketBroadridge corporate issuer solutionsPlant cell matrixSecurities actSecurities exchange actMerger agreementAnnual report

Calyxt, Inc (NASDAQ:CLXT) Short Interest Up 121 6% in April

Calyxt, Inc. (NASDAQ:CLXT – Get Rating) was the recipient of a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 83,100 shares, a growth of 121.6% from the April 15th total of 37,500 shares. Based on an average daily volume of 32,900 shares, the days-to-cover […]

Danielf voytasCalyxt incRenaissance technologiesGet ratingCalyxt dailyNasdaq clxt

Cellectis Provides Business Update and Reports Financial Results for First Quarter 2023

First r/r ALL patient dosed in Europe with Cellectis’ UCART22 product candidate manufactured in-houseCellectis implements CLLS52 for the first time in the clinic with Sanofi’s. | May 4, 2023

United statesNorth carolinaFrance generalNew yorkAshleyr robinsonPascalyne wilsonArthur strilInternational accounting standards boardBarclays capital incResearch data preclinical programsAmerican society of hematologyAmerican society of clinical oncologyCibus globalAmerican society of geneEuropean investment bankExchange commission

Cellectis S A : PRELIMINARY NOTE - Form 6-K

PRELIMINARY NOTE The unaudited condensed Consolidated Financial Statements for the three-month period ended March 31, 2023, included herein, have been prepared in. | May 4, 2023

United statesNew jerseyFrance generalUniversity of texasNew yorkIovance biotherapeuticsPontchaillou rennesMonte carloNavarra pamplonaRobert debrLos angelesTrustee of university pennsylvania philadelphiaBrigham cancer care incExchange commissionUniversity of minnesotaCalypso merger subsidiary